[HTML][HTML] Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients
Background Receptor activator of NFkB (RANK), its ligand (RANKL) and the decoy receptor
of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating …
of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating …
Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging
To evaluate diagnostic performance of endorectal magnetic resonance (eMR) for
diagnosing local recurrence of prostate cancer (PC) in patients with previous radical …
diagnosing local recurrence of prostate cancer (PC) in patients with previous radical …
Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab
U De Giorgi, G Procopio, D Giannarelli… - Clinical Cancer …, 2019 - AACR
Purpose: Inflammation indexes and body mass index (BMI) are easily evaluated, predict
survival, and are potentially modifiable. We evaluated the potential association of …
survival, and are potentially modifiable. We evaluated the potential association of …
[HTML][HTML] Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey
A Indini, C Aschele, L Cavanna, M Clerico… - European Journal of …, 2020 - Elsevier
The novel severe acute respiratory syndrome coronavirus-2 pandemic is a global health
problem, which started to affect China by the end of 2019. In Europe, Italy has faced this …
problem, which started to affect China by the end of 2019. In Europe, Italy has faced this …
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
A Necchi, L Mariani, N Zaffaroni, LH Schwartz… - The lancet …, 2012 - thelancet.com
Background The development of new drugs for patients with refractory urothelial cancer is
still an unmet medical need. Preclinical evidence lends support to a rationale for targeting of …
still an unmet medical need. Preclinical evidence lends support to a rationale for targeting of …
[HTML][HTML] Natural history of non-small-cell lung cancer with bone metastases
We conducted a large, multicenter, retrospective survey aimed to explore the impact of tumor
bone involvement in Non-Small Cell Lung Cancer. Data on clinical-pathology, skeletal …
bone involvement in Non-Small Cell Lung Cancer. Data on clinical-pathology, skeletal …
Treatment of extraspinal painful bone metastases with percutaneous cementoplasty: a prospective study of 50 patients
GC Anselmetti, A Manca, C Ortega, G Grignani… - Cardiovascular and …, 2008 - Springer
The aim of this study was to assess the efficacy of percutaneous cementoplasty (PC) with
polymethylmethacrylate (PMMA) in painful extravertebral lytic bone metastases not …
polymethylmethacrylate (PMMA) in painful extravertebral lytic bone metastases not …
Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment …
O Caffo, U De Giorgi, L Fratino, D Alesini, V Zagonel… - European urology, 2015 - Elsevier
Background The availability of new agents (NAs) active in patients with metastatic castration-
resistant prostate cancer (mCRPC) progressing after docetaxel treatment (abiraterone …
resistant prostate cancer (mCRPC) progressing after docetaxel treatment (abiraterone …
Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science
C Porta, R Sabbatini, G Procopio… - Expert review of …, 2012 - Taylor & Francis
Although over 70% of patients with metastatic renal cell carcinoma (RCC) respond to initial
therapy with tyrosine kinase inhibitors (disease control rate 70–80%), approximately 20 …
therapy with tyrosine kinase inhibitors (disease control rate 70–80%), approximately 20 …
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors
M Santoni, A Conti, S Partelli, C Porta… - Annals of Surgical …, 2015 - Springer
Background The aim of this study was to compare survival of resected and unresected
patients in a large cohort of patients with metastases to the pancreas from renal cell …
patients in a large cohort of patients with metastases to the pancreas from renal cell …